FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]

研究用のみ。 完全な免責事項 →

ペプチドライブラリー

Oxytocin

Pitocin / OXT / The Love Hormone

Sexual Health

Oxytocin is a naturally occurring nonapeptide hormone produced in the hypothalamus and released from the posterior pituitary, often referred to as the "love hormone" for its role in social bonding, trust, and attachment. It is FDA-approved as Pitocin for the induction and augmentation of labor and for the control of postpartum hemorrhage. Beyond obstetric use, it is actively researched for applications in autism spectrum disorder, social anxiety, PTSD, and pair bonding.

作用機序

Nine-amino-acid neuropeptide hormone produced in the hypothalamus. Promotes pair bonding, social trust, empathy, and orgasm. Stimulates uterine contractions and milk letdown. Modulates anxiety, stress response, and social cognition through widespread CNS receptor distribution.

研究プロトコル

研究目的のみで使用。医療アドバイスではありません。

Intranasal research protocols use 20-40 IU per dose. IV protocols (obstetric) use 10-40 units in saline infusion. Sublingual protocols under investigation. Intranasal effects on social behavior studied at single doses.

研究ノート

Clinical Research Status

Oxytocin has decades of FDA-approved use as Pitocin for labor induction, augmentation of labor, and postpartum hemorrhage control. Intranasal oxytocin (Syntocinon) is available in some countries and is extensively studied in psychiatric and behavioral research. Clinical trials for autism spectrum disorder, social anxiety, and PTSD have produced mixed but promising results, with ongoing research refining optimal dosing and target populations.

Key Published Findings

Research demonstrates oxytocin's role in enhancing trust, empathy, and social memory in healthy volunteers and clinical populations. Intranasal administration at 24-40 IU has been shown to cross the blood-brain barrier and modulate amygdala reactivity and social cognition in fMRI studies. In autism research, meta-analyses show modest improvements in social recognition and eye contact, though effect sizes vary considerably across studies and populations.

Safety Profile

Intravenous oxytocin for labor carries risks of uterine hyperstimulation, fetal distress, and rare water intoxication due to antidiuretic effects at high doses. Intranasal formulations used in research have a favorable safety profile with minimal reported adverse effects (occasional nasal irritation, mild headache). Cardiovascular effects are minimal at physiological doses, though rapid IV bolus can cause transient hypotension and reflex tachycardia.

Comparison to Related Compounds

Oxytocin is structurally similar to vasopressin (differing by only two amino acids) but has distinct receptor selectivity and physiological effects. Synthetic analogs like carbetocin have been developed with longer half-lives for obstetric use, reducing the need for continuous infusion. Unlike pharmaceutical anxiolytics, oxytocin's pro-social effects appear specific to social cognition rather than generalized anxiety reduction.

Community Observations

Intranasal oxytocin has generated significant interest in biohacking and optimization communities for its reported pro-social and anxiolytic effects in social situations. Users typically report subtle effects on social warmth and connection rather than dramatic pharmacological responses. Researchers caution that oxytocin's effects are highly context-dependent, with some studies showing increased in-group favoritism or defensive aggression in competitive contexts.

半減期

~3-5 minutes (IV); ~30 min (intranasal)

再構成

Sterile saline (injection) or pre-mixed nasal spray

保存

乾燥粉末

Refrigerate 2-8C.

再溶解

Refrigerate 2-8C. Use within 28 days for nasal formulations.

米国法的状況

FDA-approved (Rx, obstetric use)

また知られる名前

PitocinOXTThe Love Hormone

よくある質問

Oxytocinとは何ですか?

Oxytocin is a naturally occurring nonapeptide hormone produced in the hypothalamus and released from the posterior pituitary, often referred to as the "love hormone" for its role in social bonding, trust, and attachment. It is FDA-approved as Pitocin for the induction and augmentation of labor and for the control of postpartum hemorrhage. Beyond obstetric use, it is actively researched for applications in autism spectrum disorder, social anxiety, PTSD, and pair bonding.

Oxytocinはどのように作用しますか?

Nine-amino-acid neuropeptide hormone produced in the hypothalamus. Promotes pair bonding, social trust, empathy, and orgasm. Stimulates uterine contractions and milk letdown. Modulates anxiety, stress response, and social cognition through widespread CNS receptor distribution.

Oxytocinの米国での規制状況は?

FDA-approved (Rx, obstetric use)

Oxytocinの半減期は?

~3-5 minutes (IV); ~30 min (intranasal)

Oxytocinの別名は?

Pitocin, OXT, The Love Hormone

ペプチドコンタクトは、研究目的のみのための要約情報を提供しています。私たちはベンダーの文書をホスト、配布、または推奨していません。すべての分析証明書、GMP認定証明書、およびベンダーコミュニケーションは、購入者によって直接要求され、確認される必要があります。このプラットフォーム上の何らかの情報は法的、医学的、または専門的なアドバイスを構成していません。ユーザーは、適切な法律、州法、および連邦法に準拠するためにベンダー資格を検証し、購入前に遵守することに全責任を持つ必要があります。このプラットフォームを使用することで、完全な個人的責任を承認することになります。

完全な免責事項を読む